These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35087751)

  • 21. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
    Lu X; Li R; Ying Y; Zhang W; Wang W
    J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas.
    Lin Z; Zou J; Sui X; Yao S; Lin L; Wang J; Zhao J
    Sci Rep; 2022 Sep; 12(1):16285. PubMed ID: 36175606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
    Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
    Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
    [No Abstract]   [Full Text] [Related]  

  • 24. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
    Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes.
    Liu M; Wei D; Nie Q; Peng L; He L; Cui Y; Ye Y
    Taiwan J Obstet Gynecol; 2022 Jul; 61(4):663-671. PubMed ID: 35779918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unraveling the role of the circadian clock genes in cervical squamous cell carcinoma and endocervical adenocarcinoma: A prognostic indicator for prognostic, immunotherapy response, and chemotherapy sensitivity.
    Xu J; Huang X; Gou S; Luo H; Zeng S; Zhang Q; Wu Q; Chi H; Yang G
    J Cancer; 2024; 15(9):2788-2804. PubMed ID: 38577592
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
    Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
    J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Li J; Xi J
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38275602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
    Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
    [No Abstract]   [Full Text] [Related]  

  • 30. The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining.
    Ding H; Xiong XX; Fan GL; Yi YX; Chen YR; Wang JT; Zhang W
    Biomed Res Int; 2020; 2020():5478574. PubMed ID: 32351997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring Potential Regulatory Anesthetic Drugs Based on RNA Binding Protein and Constructing CESC Prognosis Model: A Study Based on TCGA Database.
    Zheng Y; Meng XW; Yang JP
    Front Surg; 2022; 9():823566. PubMed ID: 35449547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma.
    Xing XL; Yao ZY; Ou J; Xing C; Li F
    Cancer Cell Int; 2021 Nov; 21(1):591. PubMed ID: 34736453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of SLC39A4 in the prognosis, immune microenvironment, and contribution to malignant behavior in vivo and in vitro of cervical cancer.
    Zhao YC; Wang TJ; Cui J; She LZ; Zhang RF; Zhang CH
    Transl Oncol; 2024 Feb; 40():101839. PubMed ID: 38029507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Zhou J; Xu L; Zhou H; Wang J; Xing X
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma.
    Lu T; Xu R; Li Q; Zhao JY; Peng B; Zhang H; Guo JD; Zhang SQ; Li HW; Wang J; Zhang LY
    Mol Ther Oncolytics; 2021 Jun; 21():134-143. PubMed ID: 33981829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis.
    Xiong J; Guo S; Bing Z; Su Y; Guo L
    Front Genet; 2018; 9():696. PubMed ID: 30662454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
    Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
    Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma.
    Liu J; Nie S; Li S; Meng H; Sun R; Yang J; Cheng W
    Ann Transl Med; 2020 Jul; 8(14):868. PubMed ID: 32793712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and assessment of an RNA editing-based risk model for the prognosis of cervical cancer patients.
    Zhu Z; Lu J
    Medicine (Baltimore); 2024 May; 103(19):e38116. PubMed ID: 38728474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
    Meng H; Liu J; Qiu J; Nie S; Jiang Y; Wan Y; Cheng W
    DNA Cell Biol; 2020 May; 39(5):848-863. PubMed ID: 32202912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.